Precision Targeting / Affilin®-based Biotherapeutics

About Navigo Proteins

Navigo Proteins is a privately held protein engineering company specializing in the development of non-antibody binding proteins. Its core technology involves engineering highly stable, small scaffold proteins (like its Precision X® and Affilin® molecules) for two distinct applications: as custom affinity ligands for purifying biologics and as targeting modules for novel therapeutics and diagnostics. The company partners with pharmaceutical and biotech firms, positioning itself as a technology enabler for both manufacturing and drug development. With a focus on robotics-assisted selection and a specialist team, Navigo aims to provide robust, cost-effective solutions for the biopharmaceutical industry.

Therapeutic Areas